Publications: Dr Julia Choy

Back to Search

Szabados B, Abu-Ghanem Y, Grant M, Choy J, Bex A, Powles T(2020). Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors. European Urology vol. 78, (2) 276-280.

10.1016/j.eururo.2020.05.024

Abu Ghanem Y, Choy J, Jackson-Spence F, Jovaisaite A, Grant M, Bex A, Powles T, Szabados B(2020). Dynamic changes in full blood count (FBC) occurring in patients treated with immune checkpoint inhibitors (ICIs) to predict responses in patients with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology vol. 38, (15_suppl) e17110-e17110.

10.1200/jco.2020.38.15_suppl.e17110

https://qmro.qmul.ac.uk/xmlui/handle/123456789/68239

Battisti NML, Kingston B, King J, Denton A, Waters S, Sita-Lumsden A, Rehman F, Stavraka C et al.(2019). Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience. Breast Cancer Res Treat vol. 174, (3) 731-740.

10.1007/s10549-019-05134-x

Battisti N, Kingston B, King J, Denton A, Waters S, Sita-Lumsden A, Rehman F, Stavraka C et al. (2019). Abstract P6-18-23: Palbociclib and endocrine therapy in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: The UK compassionate access program experience.

10.1158/1538-7445.sabcs18-p6-18-23

Back to Search